Manufacturer record
Azot Life Sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Azot Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between April 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Azot Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP | AT-1952AMfg 2025-06 · Exp 2027-05 | Content of Pantoprazole (84.7%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Burmoxicla+V(Amoxycill in & Potassium Clavulanate Oral Suspension IP) | ABD-187CMfg 2024-06 · Exp 2025-11 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with Clavulanic Acid in Potassium Clavulanate respect to the content ofOther | DTL MaduraiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.